Results 1 to 10 of about 7,658 (215)
Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease [PDF]
Clinics, 2011 OBJECTIVE: To compare superior ophthalmic vein blood flow parameters measured with color Doppler imaging in patients with congestive Graves' orbitopathy before and after treatment and in normal controls.
Mário L. R. Monteiro +3 more
doaj +6 more sources
Asymmetric Graves’ Orbitopathy [PDF]
Frontiers in Endocrinology, 2020 Graves’ Orbitopathy (GO) is an autoimmune orbital disorder usually presenting as a sequala of autoimmune thyroid disease. The presence of GO is associated with increased psychological burden and, in severe cases may cause blindness.
Grigorios Panagiotou, Petros Perros
doaj +4 more sources
Orbital Signaling in Graves’ Orbitopathy [PDF]
Frontiers in Endocrinology, 2021 Graves’ orbitopathy (GO) is a complex and poorly understood disease in which extensive remodeling of orbital tissue is dominated by adipogenesis and hyaluronan production.
Mohd Shazli Draman +4 more
doaj +5 more sources
Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
Frontiers in Endocrinology, 2017 IntroductionGraves’ orbitopathy is the extra thyroidal manifestation of Graves’ disease and the most common cause of exophthalmos. It is also known as thyroid-associated orbitopathy (TAO) as it occasionally occurs in euthyroid or hypothyroid patients ...
Vibhor Wadhwa, Gitanjali Bajaj
exaly +3 more sources
Current concepts regarding Graves’ orbitopathy
Journal of Internal Medicine, 2022 AbstractGraves’ orbitopathy (GO) is an orbital autoimmune disorder and the main extrathyroidal manifestation of Graves’ disease, the most common cause of hyperthyroidism. GO affects about 30% of Graves’ patients, although fewer than 10% have severe forms requiring immunosuppressive treatments.
Luigi Bartalena, Maria Laura Tanda
exaly +3 more sources
Adipocytokines in Graves’ orbitopathy and the effect of high-dose corticosteroids
Adipocyte, 2021 Graves’ orbitopathy (GO) is a serious, progressive eye condition seen in patients with autoimmune thyroid disease. GO is characterized by inflammation and swelling of soft orbital tissues. Adipose tissue produces cytokine mediators called adipokines. The
Jan Schovanek, Michal Křupka
exaly +2 more sources
Steroid-resistant Graves' orbitopathy: Therapeutic options [PDF]
Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor", 2023 Graves orbitopathy is the most common extrathyroidal manifestation of autoimmune hyperthyroidism, although it can rarely occur in euthyroid and hypothyroid patients.
Klet Sanja +6 more
doaj +1 more source
Frontiers in Endocrinology, 2022 BackgroundImmunosuppressive therapy of Graves’ orbitopathy (GO) is indicated during the active phase of disease. Intravenous steroids (IVGC) are effective in about 70% of patients, although unresponsiveness or relapse are observed.
Irene Campi +16 more
doaj +1 more source
Pediatric Graves’ orbitopathy: a multicentre study [PDF]
Acta Ophthalmologica, 2021 AbstractPurposeGraves’ orbitopathy (GO) is a rare condition in children often considered to be a less severe condition than at an older age. The aim of our study was to analyse if there are any factors that distinguish paediatric from adult GO in order to provide guidelines for assessing and managing paediatric GO.MethodsStudy design is a multicentre ...
Ionescu, Ioana C +10 more
openaire +4 more sources